While Latisse is known throughout the world for its remarkable effects on eyelash lengthening and thickening, the medication was originally designed as eye drops to control the progression of glaucoma.
The drug, medicinally called bimatoprost was found to increase the amount of aqueous fluid in the eye, reducing the intraocular pressure caused by glaucoma. Serendipitously, it was soon found to have off-label uses, particularly for lengthening, thickening and darkening the lashes. In 2008, a dilute solution of bimatoprost called Latisse was officially approved by the FDA for cosmetic usage. People have been enjoying the benefits of Latisse ever since.
A small number of patients may experience temporary irritation or redness, and an even smaller number has experienced temporary skin darkening at the application point. If this occurs, it will disappear once you discontinue the use of Latisse. In rare cases, the use of Latisse may cause permanent changes to the iris, particularly with lighter coloured eyes, causing brown pigmentation. While such changes have not occurred in clinical trials for Latisse, they have been noticed by users of Lumigan, the trade name for bimatoprost used by sufferers of glaucoma. This is likely due to the fact that Lumigan is applied directly to the eye, and at a much great concentration. Careful application of Latisse to the upper lid margin should not cause pigmentation changes in the iris.
If so, contact Dr. Weber's Cosmetic Clinic today by calling 705.828.3223 or by filling in our secure online appointment request form for a complimentary consultation with our experienced and knowledgeable staff.
Looking to learn more about our clinic, a procedure or solutions to a concern you may have? Submit your inquiry and we will connect back with you as quickly as possible.